| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1,250 | 0.22% | $206.15 | +$257,688 |
| Sells | 7 | -575,780 | 100% | $212.49 | -$122,346,999 |
| Net | -6 | -574,530 | -100% | -$122,089,312 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Alex Gorsky | Director | $132,153,735 | 17 Jan 2023 | ||
| Joaquin Duato | CEO and Chairman of the Board, Director | $88,349,558 | -$44,671,548 | -34% | 13 Feb 2026 |
| Jennifer L. Taubert | EVP, WWC. Innovative Medicine | $48,204,011 | -$10,040,883 | -17% | 13 Feb 2026 |
| Michael H. Ullmann | Exec VP, General Counsel | $31,906,242 | 14 Feb 2022 | ||
| Kathryn E. Wengel | EVP, Chief TO and Risk Officer | $28,204,107 | 13 Feb 2026 | ||
| Peter Fasolo | Exec VP, Chief HR Officer | $21,756,253 | 15 Feb 2024 | ||
| Joseph J. Wolk | Exec VP, CFO | $20,446,898 | -$24,743,398 | -55% | 13 Feb 2026 |
| Thibaut Mongon | Exec VP, WW Chair, Cons Health | $15,974,106 | 13 Feb 2023 | ||
| Mathai Mammen | EVP, Pharm, R&D | $10,751,687 | 14 Feb 2022 | ||
| JOHN C. REED | EVP, Innovative Medicine, R&D | $10,315,169 | -$20,420,856 | -66% | 15 Feb 2026 |
| James D. Swanson | Evp, Cio | $10,018,736 | -$15,109,759 | -60% | 13 Feb 2026 |
| William Hait | EVP, Chief EI and Med Officer | $9,578,502 | 15 Feb 2024 | ||
| Ashley McEvoy | EVP, WW Chair, MedTech | $9,484,760 | 23 Aug 2023 | ||
| Vanessa Broadhurst | EVP, Global Corp Affairs | $8,400,124 | -$1,508,288 | -15% | 13 Feb 2026 |
| Timothy Schmid | EVP, WW Chair, MedTech | $6,911,910 | -$5,852,268 | -46% | 20 Feb 2026 |
| Elizabeth Forminard | EVP, Chief Legal Officer | $6,235,591 | 13 Feb 2026 | ||
| Robert J. Decker | VP Corporate Controller | $6,103,083 | 13 Feb 2026 | ||
| Kristen Mulholland | EVP, Chief HR Officer | $5,096,972 | 13 Feb 2026 | ||
| A. Eugene Washington | Director | $4,542,828 | 07 Mar 2023 | ||
| RONALD A. WILLIAMS | Director | $4,082,264 | 15 Feb 2022 | ||
| CHARLES PRINCE | Director | $3,947,229 | 15 Feb 2022 | ||
| ANNE M. MULCAHY | Director | $3,481,675 | 25 Apr 2024 | ||
| Mark B. McClellan | Director | $2,897,429 | 24 Apr 2025 | ||
| MARILLYN A. HEWSON | Director | $2,860,628 | 09 Dec 2025 | ||
| Ian Davis | Director | $2,815,437 | 15 Feb 2022 | ||
| D. SCOTT DAVIS | Director | $2,589,274 | 25 Apr 2024 | ||
| Mary C. Beckerle | Director | $2,212,351 | 24 Apr 2025 | ||
| MARK A. WEINBERGER | Director | $1,627,636 | 24 Apr 2025 | ||
| Jennifer A. Doudna | Director | $1,310,518 | 24 Apr 2025 | ||
| Eugene A. Woods | Director | $1,058,719 | 09 Dec 2025 | ||
| Hubert Joly | Director | $1,048,226 | 24 Apr 2025 | ||
| Nadja West | Director | $825,991 | 24 Apr 2025 | ||
| Darius Adamczyk | Director | $602,052 | 25 Apr 2024 | ||
| Paula A. Johnson | Director | $481,960 | 24 Apr 2025 | ||
| JOHN G. MORIKIS | Director | $381,070 | +$257,688 | +209% | 26 Nov 2025 |
| Daniel E. Pinto | Director | $66,948 | 09 Dec 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|